comparemela.com

Montpellier (France), April, 5, 2022 - 8:45am – Medesis Pharma (ISIN: FR0010844464, Ticker: ALMDP), a pharmaceutical biotechnology company developing drug candidates with its proprietary buccal active ingredient delivery technology, Aonys®, publishes an information note on the three future drugs in develop...

Related Keywords

Canada ,France ,Brazil ,Ukraine ,French ,Medesis Pharma ,French Atomic Energy Commission ,Armed Forces Biomedical Research Institute ,French Defense Innovation Agency ,Nuclear Power Plants ,Medicines Agency ,French Defense Innovation ,Prussian Blue ,Maladie De Huntington ,Euronext Growth ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.